Cas:335081-06-6 2-aminobenzoic acid manufacturer & supplier

We serve Chemical Name:2-aminobenzoic acid CAS:335081-06-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-aminobenzoic acid

Chemical Name:2-aminobenzoic acid
CAS.NO:335081-06-6
Synonyms:2-Aminobenzoic acid-13C6;2-AA-13C6
Molecular Formula:C7H7NO2
Molecular Weight:143.09200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:63.32000
Exact Mass:143.06800
LogP:1.54820

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Aminobenzoic acid-13C6 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-AA-13C6 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Aminobenzoic acid-13C6 Use and application,2-Aminobenzoic acid-13C6 technical grade,usp/ep/jp grade.


Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. 2-aminobenzoic acid manufacturer There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 2-aminobenzoic acid supplier Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. 2-aminobenzoic acid vendor In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . 2-aminobenzoic acid factory Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.